Gastrointestinal Manifestations of COVID-19 in a South Asian Population: Early Pandemic Insights

Authors

  • Abdul Hadi Shahid Medical College, Aga Khan University, Karachi 74800, Pakistan Author
  • Masood Muhammad Karim Section of Gastroenterology, Department of Medicine, Aga Khan University, Karachi 74800, Pakistan Author
  • Zahabia Sohail Section of Gastroenterology, Department of Medicine, Aga Khan University, Karachi 74800, Pakistan Author
  • Amna Rashid Hanfee Medical College, Aga Khan University, Karachi 74800, Pakistan Author
  • Zaibunnisa Kamran Medical College, Aga Khan University, Karachi 74800, Pakistan Author
  • Om Parkash Section of Gastroenterology, Department of Medicine, Aga Khan University, Karachi 74800, Pakistan Author

DOI:

https://doi.org/10.64229/35650n59

Keywords:

COVID-19, Gastrointestinal symptoms, Pandemic, Viral infection, Extra pulmonary symptoms

Abstract

Background: COVID-19 has affected millions globally. Initially, attention focused on pulmonary disease, but gastrointestinal (GI) and hepatobiliary manifestations soon emerged as significant components. Reported GI symptom prevalence ranges from 17% to 53%, though most evidence originates from high-income countries and later variant waves. Limited data exist from South Asia during the early wild-type phase. This study aimed to determine the frequency and characteristics of GI presentations among patients with PCR-confirmed COVID-19 in a South Asian setting. Methods: This retrospective cross-sectional study was conducted at Aga Khan University Hospital, Karachi, Pakistan. Patients aged ≥18 years with PCR-confirmed COVID-19 between February and June 2020 were included. Data were extracted from medical records and independently verified by two researchers. Statistical analysis was performed using SPSS Version 24. Results: Among 534 patients, the median age was 55 years (IQR: 24), with 61.4% male. Common symptoms included fever (72.7%), cough (55.7%), and shortness of breath (55.1%). GI symptoms included nausea (24.3%), diarrhea (15.7%), vomiting (15.0%), ageusia (9.2%), and jaundice (4.5%), while abdominal pain was uncommon (4.1%). No major GI complications were reported. Elevated SGOT, GGT, and SGPT were observed in 81%, 69.4%, and 66.8% of patients, respectively. Conclusions: GI symptoms were a notable component of COVID-19 presentations in our population during the early pandemic phase. Recognizing these manifestations supports timely diagnosis and management. The findings provide regional baseline data for comparison with later variants and underscore the need for studies on long-term GI outcomes.

References

[1]Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J. The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature, 2023, 613(7942), 130-137. DOI: 10.1038/s41586-022-05522-2

[2]Parasa S, Desai M, Thoguluva Chandrasekar V, Patel HK, Kennedy KF, Roesch T, Spadaccini M, et al. Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis. JAMA Network Open, 2020, 3(6), e2011335. DOI: 10.1001/jamanetworkopen.2020.11335

[3]Natarajan A, Zlitni S, Brooks EF, Vance SE, Dahlen A, Hedlin H, et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med, 2022, 3(6), 371-387.e9. DOI: 10.1016/j.medj.2022.04.001

[4]Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nature Medicine, 2020, 26(7), 1017-1032. DOI: 10.1038/s41591-020-0968-3

[5]Shih AR, Misdraji J. COVID-19: Gastrointestinal and hepatobiliary manifestations. Human Pathology, 2023, 132, 39-55. DOI: 10.1016/j.humpath.2022.07.006

[6]Mohamed AA, Alharbi M, Mohamed SA. Acute abdomen is a rare presentation of COVID-19 in the absence of respiratory manifestations: A case report. Cureus, 2023, 15(7), e42518. DOI: 10.7759/cureus.42518

[7]Jha AK, Suchismita A, Jha RK, Raj VK. Spectrum of gastrointestinal involvement in Stevens - Johnson syndrome. World Journal of Gastrointestinal Endoscopy, 2019, 11(2), 115-123. DOI: 10.4253/wjge.v11.i2.115

[8]Fakharian F, Thirugnanam S, Welsh DA, Kim WK, Rappaport J, Bittinger K, et al. The role of gut dysbiosis in the loss of intestinal immune cell functions and viral pathogenesis. Microorganisms, 2023, 11(7), 1849. DOI: 10.3390/microorganisms11071849

[9]Dorrell RD, Dougherty MK, Barash EL, Lichtig AE, Clayton SB, Jensen ET. Gastrointestinal and hepatic manifestations of COVID-19: A systematic review and meta-analysis. JGH Open, 2020, 5(1), 107-115. DOI: 10.1002/jgh3.12456

[10]Akin H, Kurt R, Tufan F, Swi A, Ozaras R, Tahan V, et al. Newly reported studies on the increase in gastrointestinal symptom prevalence with COVID-19 infection: A comprehensive systematic review and meta-analysis. Diseases, 2020, 8(4), 41. DOI: 10.3390/diseases8040041

[11]Tariq R, Saha S, Furqan F, Hassett L, Pardi D, Khanna S. Prevalence and mortality of COVID-19 patients with gastrointestinal symptoms: A systematic review and meta-analysis. Mayo Clinic Proceedings, 2020, 95(8), 1632-1648. DOI: 10.1016/j.mayocp.2020.06.003

[12]Slabakova Y, Gerasoudis S, Miteva D, Peshevska-Sekulovska M, Batselova H, Snegarova V, et al. SARS-CoV-2 variant-specific gastrointestinal symptoms of COVID-19: 2023 update. Gastroenterol Insights, 2023, 14(4), 431-445. DOI: 10.3390/gastroent14040032

[13]Cuicchi D, Gabrielli L, Tardio ML, Rossini G, D'Errico A, Viale P, et al. Virological and histological evaluation of intestinal samples in COVID-19 patients. World Journal of Gastroenterology, 2022, 28(44), 6282-6293. DOI: 10.3748/wjg.v28.i44.6282

[14]Cárdenas-Jaén K, Sánchez-Luna SA, Vaillo-Rocamora A, Castro-Zocchi MR, Guberna-Blanco L, Useros-Brañas D, et al. Gastrointestinal symptoms and complications in patients hospitalized due to COVID-19, an international multicentre prospective cohort study (TIVURON project). Gastroenterología y Hepatología, 2023, 46(6), 425-438. DOI: 10.1016/j.gastrohep.2022.10.007

[15]Marasco G, Cremon C, Barbaro MR, Salvi D, Cacciari G, Kagramanova A, et al. Prevalence of gastrointestinal symptoms in severe acute respiratory syndrome coronavirus 2 infection: Results of the prospective controlled multinational GI-COVID-19 Study. American Journal of Gastroenterology, 2022, 117(1), 147-157. DOI: 10.14309/ajg.0000000000001541

[16]Chen A, Agarwal A, Ravindran N, To C, Zhang T, Thuluvath PJ. Are gastrointestinal symptoms specific for coronavirus 2019 infection? A prospective case-control study from the United States. Gastroenterology, 2020, 159(3), 1161-1163. e2. DOI: 10.1053/j.gastro.2020.05.036

[17]Lak E, Sheikholeslami SA, Ghorbi MD, Shafei M, Yosefi H. Association between gastrointestinal symptoms and disease severity in patients with COVID-19 in Tehran City, Iran. Przegląd Gastroenterologiczny, 2022, 17(1), 52-58. DOI: 10.5114/pg.2021.106245

[18]Abbasi AH, Zameer A, Umar A, Andaleeb H, Ahmed KA, Yousuf N. Prevalence of different gastrointestinal manifestations in patients with COVID-19 presenting to gastroenterology OPD at Rawal Institute of Health Sciences, Islamabad. Pakistan Journal of Medical & Health Sciences, 2023, 17(4), 381. DOI: 10.53350/pjmhs2023174381

[19]de-Madaria E, Capurso G. COVID-19 and acute pancreatitis: Examining the causality. Nature Reviews Gastroenterology & Hepatology, 2021, 18(1), 3-4. DOI: 10.1038/s41575-020-00389-y

[20]Ribeiro-Junior MAF, Augusto SS, Elias YGB, Costa CTK, Néder PR. Gastrointestinal complications of coronavirus disease (COVID-19). Arquivos Brasileiros de Cirurgia Digestiva, 2022, 34(3), e1620. DOI: 10.1590/0102-672020210002e1620

[21]Gulen M, Satar S. Uncommon presentation of COVID-19: Gastrointestinal bleeding. Clinics and Research in Hepatology and Gastroenterology, 2020, 44(4), e72-e76. DOI: 10.1016/j.clinre.2020.05.001

[22]Rubin R. SARS-CoV-2 RNA can persist in stool months after respiratory tract clears virus. JAMA, 2022, 327(22), 2175-2176. DOI: 10.1001/jama.2022.7892

[23]Zhang H, Shao B, Dang Q, Chen Z, Zhou Q, Luo H, et al. Pathogenesis and mechanism of gastrointestinal infection with COVID-19. Frontiers in Immunology, 2021, 12, 674074. DOI: 10.3389/fimmu.2021.674074

[24]Lewandowski K, Kaniewska M, Rosołowski M, Rydzewska G. Gastrointestinal symptoms in COVID-19. Przegląd Gastroenterologiczny, 2023, 18(1), 61-66. DOI: 10.5114/pg.2021.112683

[25]Tahsini Tekantapeh S, Mikaeili H, Soleimanpour H. The role of respiratory system surface area and ventilation volume in severity and mortality of COVID-19 infection. Frontiers in Emergency Medicine, 2021, 5(3), e27. DOI: 10.18502/fem.v5i3.5889

[26]Gholami N, Tahsini Tekantapeh S, Khalaji A, Nejati B, Ravaei G. Primary (AL) amyloidosis following COVID-19 infection: A case report. Clinical Case Reports, 2026, 14(2), e71871. DOI: 10.1002/ccr3.71871

[27]El Ouali S, Achkar JP, Lashner B, Regueiro M. Gastrointestinal manifestations of COVID-19. Cleveland Clinic Journal of Medicine, 2021, 88(2), 63-69. DOI: 10.3949/ccjm.87a.ccc049

[28]Tekantapeh ST, Safarkhanlou P, Mirzohreh ST, Jahangiri R, Khabbazi A. COVID-19 vaccine-induced autoimmune rheumatic diseases: A systematic review of case reports. Current Rheumatology Reviews, 2026. DOI: 10.2174/0115733971459198260722053837

Downloads

Published

2026-09-21

Issue

Section

Articles

How to Cite

Shahid, A. H., Karim, M. M., Sohail, Z., Hanfee, A. R., Kamran, Z. ., & Parkash, O. (2026). Gastrointestinal Manifestations of COVID-19 in a South Asian Population: Early Pandemic Insights. Gastroenterology Nexus, 1(1), 49-56. https://doi.org/10.64229/35650n59